Back to Publications
Process Engineering9 min read

Bioprocessing Scale-Up: Single-Use Bioreactors (SUB) vs. Stainless Steel Stirred Tanks for mAbs and Recombinant Proteins

Kiran SeepanaSeptember 22, 20265 Views
Executive Summary & Scope

Master mammalian cell culture scale-up for monoclonal antibodies. Compare Single-Use Bioreactors (SUB) vs. stainless steel, volumetric mass transfer (kLa), Kolmogorov shear dissipation, and pCO2 stripping.

Peer-Reviewed & PE Verified

ASME VIII • NFPA 68/69 • TEMA • ISO 9001 Alignment

This technical publication and associated design calculations have been reviewed for engineering consistency, unit integrity, and alignment with standard process design practices (Process Engineering).

# Bioprocessing Scale-Up: Single-Use Bioreactors (SUB) vs. Stainless Steel Stirred Tanks for mAbs and Recombinant Proteins

# Quantitative Transport Phenomena, Oxygen Mass Transfer (kLak_L a), Kolmogorov Shear Dissipation, and Techno-Economics in Modern Biomanufacturing


# Executive Summary

The global biopharmaceutical industry has undergone a monumental structural pivot toward high-titer Monoclonal Antibodies (mAbs), Antibody-Drug Conjugates (ADCs), bispecific antibodies, and recombinant therapeutic enzymes. Modern fed-batch Chinese Hamster Ovary (CHO) cell cultures routinely reach viable cell densities (VCD\text{VCD}) exceeding 20–35×106 cells/mL20\text{–}35 \times 10^6\text{ cells/mL} and expression titers of 4 to 8 g/L4\text{ to }8\text{ g/L}.

As biological titers have climbed, facility engineering has transformed. The historical standard of massive 10,000–20,000 L10,000\text{–}20,000\text{ L} stainless steel (SS) bioreactor facilities is increasingly challenged by modular 500–2,000 L500\text{–}2,000\text{ L} Single-Use Bioreactors (SUB) utilizing gamma-irradiated polymer bag liners.

However, scaling mammalian cell culture is governed by delicate, highly constrained transport physics:

  1. Oxygen Mass Transfer Bottlenecks: Meeting elevated Oxygen Uptake Rates (OUROUR) requires volumetric mass transfer coefficients (kLa≥25 h−1k_L a \ge 25\text{ h}^{-1}) without inducing high-velocity bubble shearing.
  2. Kolmogorov Shear Stress vs. Cell Fragility: Unlike robust bacteria (E. coli), wall-less mammalian cells are susceptible to hydrodynamic shear. The local Kolmogorov eddy length scale (ηk\eta_k) must never approach the eukaryotic cell diameter (12–20μm12\text{–}20\mu\text{m}).
  3. Dissolved Carbon Dioxide (pCO2pCO_2) Toxicity: While sparging pure oxygen satisfies DODO, inadequate gas velocity fails to strip metabolic CO2CO_2. Accumulation of pCO2>120–150 mmHgpCO_2 > 120\text{–}150\text{ mmHg} drives medium acidification, increases base addition, elevates osmotic pressure (>380 mOsm/kg>380\text{ mOsm/kg}), and severely degrades antibody glycosylation profiles.

This technical guide provides the fundamental bio-transport derivations, hardware hydrodynamic comparisons, and a fully worked industrial scale-up case study from a 50 L seed bioreactor to a 2,000 L commercial Single-Use Bioreactor (SUB).


# 1. Gas-Liquid Oxygen Mass Transfer: The kLak_L a Transport Model

In aerobic cellular metabolism, oxygen is sparingly soluble in aqueous nutrient broths (C∗≈0.21 mmol/LC^* \approx 0.21\text{ mmol/L} at 37∘C37^\circ\text{C} in ambient air). The bioreactor must continuously deliver oxygen across the gas-liquid interface to match the metabolic consumption of the culture:

OTR=kLa⋅(C∗−CL)\text{OTR} = k_L a \cdot (C^* - C_L)
OUR=qO2⋅Xv\text{OUR} = q_{\text{O}_2} \cdot X_v

Where:

  • OTR\text{OTR}: Oxygen Transfer Rate (mmol/L⋅h\text{mmol/L}\cdot\text{h})
  • OUR\text{OUR}: Oxygen Uptake Rate (mmol/L⋅h\text{mmol/L}\cdot\text{h})
  • kLak_L a: Volumetric gas-liquid mass transfer coefficient (h−1\text{h}^{-1})
  • C∗C^*: Saturated dissolved oxygen concentration at operating temperature and pressure (mmol/L\text{mmol/L})
  • CLC_L: Bulk dissolved oxygen concentration in liquid broth (mmol/L\text{mmol/L}, typically maintained at 30–50%30\text{–}50\% air saturation)
  • qO2q_{\text{O}_2}: Specific cellular oxygen consumption rate (≈0.25 to 0.45 pmol/cell⋅h\approx 0.25\text{ to }0.45\text{ pmol/cell}\cdot\text{h} for CHO)
  • XvX_v: Viable cell density (cells/mL\text{cells/mL})
         Gas Sparger Bubble (Pure O2 / Air)
                       │
                       ▼
       ┌───────────────────────────────┐
       │ Gas Film Resistance (Neglig.) │
       ├───────────────────────────────┤ ◄── Gas-Liquid Interface
       │ Liquid Film Resistance (1/kL) │ ◄── Rate-Limiting Barrier (Film Thickness δ)
       ├───────────────────────────────┤
       │ Bulk Nutrient Medium (CL)     │
       └───────────────┬───────────────┘
                       ▼
            Mammalian CHO Cell (OUR = qO2 · Xv)

# 1.1 The Van 't Riet Correlation for Bioreactors

The volumetric mass transfer coefficient is parameterized by agitator power dissipation per unit volume (P/VP/V) and superficial sparge gas velocity (ugu_g):

kLa=C⋅(PV)α⋅(ug)βk_L a = C \cdot \left(\frac{P}{V}\right)^\alpha \cdot (u_g)^\beta

For non-coalescing biological media containing surfactants (such as Pluronic F-68 / Poloxamer 188), typical exponents are:

α≈0.40−0.60,β≈0.45−0.70\alpha \approx 0.40 - 0.60, \quad \beta \approx 0.45 - 0.70

# 1.2 Bubble Dynamics & Specific Interfacial Area (aa)

The volumetric mass transfer coefficient kLak_L a is the product of the liquid-film mass transfer coefficient (kLk_L) and the specific interfacial surface area (aa):

a=6⋅ϕgasd32a = \frac{6 \cdot \phi_{gas}}{d_{32}}

Where:

  • ϕgas\phi_{gas}: Gas phase holdup fraction (m3 gas / m3 liquid\text{m}^3\text{ gas / m}^3\text{ liquid}, typically 0.02−0.080.02 - 0.08)
  • d32d_{32}: Sauter mean bubble diameter (m\text{m})

The Sauter mean bubble diameter is governed by the equilibrium between turbulent shear breakup and bubble coalescence:

d32=Cb⋅(σL0.6(P/V)0.4⋅ρL0.2)⋅(ρLρG)0.2d_{32} = C_b \cdot \left( \frac{\sigma_L^{0.6}}{(P/V)^{0.4} \cdot \rho_L^{0.2}} \right) \cdot \left( \frac{\rho_L}{\rho_G} \right)^{0.2}

  • Microspargers (20–40μm20\text{–}40\mu\text{m} frits): Generate tiny bubbles (d32≈0.5–1.0 mmd_{32} \approx 0.5\text{–}1.0\text{ mm}), creating an immense interfacial area (a>250 m2/m3a > 250\text{ m}^2/\text{m}^3) that achieves high kLak_L a at very modest gas flow rates.
  • Macrospargers (1.0–2.0 mm1.0\text{–}2.0\text{ mm} drilled holes): Generate larger bubbles (d32≈3–5 mmd_{32} \approx 3\text{–}5\text{ mm}), which minimize surface cell disruption upon bursting and provide high volumetric buoyancy for stripping volatile metabolic byproducts.

# 2. Shear Stress & The Kolmogorov Microscale of Turbulence

A persistent myth in bioprocess scale-up is that "impeller tip speed kills mammalian cells." In reality, empirical hydrodynamic research confirms that bulk laminar shear in stirred tanks is rarely lethal to cells protected by Pluronic surfactants.

Cell lysis occurs predominantly in two specific physical regimes:

  1. The Bubble Disruption / Cavitation Zone at the Surface: As sparged gas bubbles burst at the liquid-gas headspace interface, the collapsing fluid jet exerts localized shear stresses exceeding 100–300 Pa100\text{–}300\text{ Pa}, shredding adjacent cell membranes.
  2. Microscale Turbulent Eddy Dissipation: When energy dissipation rates (εturb=P/(ρV)\varepsilon_{turb} = P / (\rho V)) in the impeller discharge stream become extreme, the smallest turbulent eddies become smaller than the cell diameter.

# 2.1 The Kolmogorov Microscale Equation

ηk=(ν3εmax)1/4\eta_k = \left( \frac{\nu^3}{\varepsilon_{max}} \right)^{1/4}

Where:

  • ηk\eta_k: Kolmogorov eddy length scale (m\text{m})
  • ν\nu: Kinematic broth viscosity (≈1.0×10−6 m2/s\approx 1.0 \times 10^{-6}\text{ m}^2/\text{s})
  • εmax\varepsilon_{max}: Maximum local turbulent energy dissipation rate (W/kg\text{W/kg})
   Eddy Size (ηk) >> Cell Diameter (d_cell ≈ 15 µm)  ──► Safe: Cells Carried Along Streamlines
   Eddy Size (ηk) ≈ Cell Diameter (d_cell ≈ 15 µm)  ──► LETHAL: Turbulent Energy Shreds Membrane!
📌 Important
Hydrodynamic Rule of Thumb: For mammalian CHO cultures, ensure that ηk>20–25μm\eta_k > 20\text{–}25\mu\text{m} across all operational impeller speeds. In practical terms, local maximum power dissipation should not exceed εmax≤1.5–2.5 W/kg\varepsilon_{max} \le 1.5\text{–}2.5\text{ W/kg}.

# 3. Dissolved Carbon Dioxide (pCO2pCO_2) Stripping Dynamics

While oxygen transfer is driven by high concentration gradients, carbon dioxide removal is governed by fluid liquid-to-gas stripping:

CTR=kLaCO2⋅(CCO2,L−CCO2∗)\text{CTR} = k_L a_{\text{CO}_2} \cdot \left( C_{\text{CO}_2, L} - C_{\text{CO}_2}^* \right)
Where: kLaCO2≈0.85×kLaO2\text{Where: } k_L a_{\text{CO}_2} \approx 0.85 \times k_L a_{\text{O}_2}

In small-scale laboratory bioreactors (3–10 L3\text{–}10\text{ L}), the headspace surface-area-to-volume ratio (Asurface/VA_{surface}/V) is large, allowing metabolic CO2CO_2 to desorb effortlessly.

At commercial scale (2,000 L2,000\text{ L} SUB or 12,000 L12,000\text{ L} SS):

  • Asurface/VA_{surface}/V collapses by over 80%80\%.
  • Hydrostatic liquid height (HL≈1.8–3.5 mH_L \approx 1.8\text{–}3.5\text{ m}) increases the bottom partial pressure of CO2CO_2.
  • If operators rely solely on pure oxygen sparging at low total gas flow (ug<0.002 m/su_g < 0.002\text{ m/s}) to meet DODO, pCO2pCO_2 rapidly exceeds 140 mmHg140\text{ mmHg}.
High pCO2 (>140 mmHg) ──► Acidifies Medium (pH Drops) ──► Auto-Addition of NaOH / Na2CO3
                                                                   │
                                                                   ▼
Glycosylation Defects & Early Apoptosis ◄── Elevated Osmolality (>380 mOsm/kg)

# 3.1 Gas-Liquid Transfer Equivalence for Carbon Dioxide

Because both oxygen absorption and carbon dioxide desorption occur across the same boundary layer film, the mass transfer coefficient for CO2CO_2 is scaled directly by molecular diffusivity via penetration theory:

kLaCO2=DCO2DO2⋅kLaO2≈0.91×kLaO2k_L a_{\text{CO}_2} = \sqrt{\frac{D_{\text{CO}_2}}{D_{\text{O}_2}}} \cdot k_L a_{\text{O}_2} \approx 0.91 \times k_L a_{\text{O}_2}

However, while oxygen transfer benefits from high concentration gradients (driving force ΔC≈C∗−CL\Delta C \approx C^* - C_L), CO2CO_2 stripping is strictly volumetric-flow limited:
Mass Stripped=V˙gas⋅PCO2R⋅T\text{Mass Stripped} = \dot{V}_{gas} \cdot \frac{P_{\text{CO}_2}}{R \cdot T}
If the total sparge gas flow rate (ballast air) is insufficient (<0.05 vvm<0.05\text{ vvm}), metabolic CO2CO_2 accumulates regardless of agitator speed.


# 4. Hardware Comparison: Single-Use Bioreactor (SUB) vs. Stainless Steel (SS)

       Single-Use Bioreactor (SUB)                      Stainless Steel Bioreactor (SS)
┌──────────────────────────────────────┐          ┌──────────────────────────────────────┐
│ • Pre-sterilized Multi-layer Bag    │          │ • Electropolished 316L Stainless     │
│ • Bottom-mounted Angled Impeller    │          │ • Dual/Triple Rushton/Hydrofoil      │
│ • Microsparger + Drilled Tube Sparge │          │ • Fixed Ring Sparger                 │
│ • Zero Cleaning Validation Required │          │ • Full CIP/SIP Steam Distribution    │
│ • Volume Capped at 2,000 - 6,000 L  │          │ • Scalable to 20,000 L Commercial    │
└──────────────────────────────────────┘          └──────────────────────────────────────┘
ParameterSingle-Use Bioreactor (2,000 L SUB)Stainless Steel Bioreactor (2,000 L SS)Commercial Scale-Up Implication
Capital Expenditure (CapEx)Low (0.35×0.35\times baseline)High (1.0×1.0\times baseline)SUB enables faster facility construction and lower initial capital risk.
Operating Cost per BatchHigh (Disposable bag costs \12k–\25k)Low (Utility steam and WFI costs)SS is significantly cheaper per liter at continuous multi-ton scale.
Changeover Turnaround Time2–4 hours2\text{–}4\text{ hours}24–48 hours24\text{–}48\text{ hours}SUB eliminates CIP/SIP cycle times, maximizing plant asset utilization.
Max Power Input (P/VP/V)0.05−0.15 kW/m30.05 - 0.15\text{ kW/m}^30.10−0.40 kW/m30.10 - 0.40\text{ kW/m}^3SUB agitation is constrained by magnetic drive/shaft seal limitations.
Aspect Ratio (H/TH/T)Typically 1.2:1−1.5:11.2:1 - 1.5:1Typically 1.8:1−2.5:11.8:1 - 2.5:1SS provides longer gas residence time, enhancing oxygen absorption.
Leachables / Extractables RiskPotential (bDtBPP antioxidant degradation)Negligible (Trace metal passivation)SUB requires comprehensive BPOG extractable validation profiles.

# 5. Worked Industrial Scale-Up Case Study: Scaling a mAb Process to 2,000 L SUB

# 5.1 Process Baseline in Seed Bioreactor

  • Cell Line: Recombinant CHO-DG44 producing humanized IgG1 mAb.
  • Peak Viable Cell Density: Xv,max=28×106 cells/mLX_{v,max} = 28 \times 10^6\text{ cells/mL}.
  • Specific Oxygen Consumption (qO2q_{\text{O}_2}): 0.32 pmol/cell⋅h=3.2×10−10 mmol/cell⋅h0.32\text{ pmol/cell}\cdot\text{h} = 3.2 \times 10^{-10}\text{ mmol/cell}\cdot\text{h}.
  • Maximum Required OUR\text{OUR}:
OURmax=(3.2×10−10 mmol/cell⋅h)×(28×109 cells/L)=8.96 mmol/L⋅h\text{OUR}_{max} = (3.2 \times 10^{-10}\text{ mmol/cell}\cdot\text{h}) \times (28 \times 10^9\text{ cells/L}) = \mathbf{8.96\text{ mmol/L}\cdot\text{h}}
  • Dissolved Oxygen Setpoint: 40%40\% air saturation (CL=0.40×0.21 mmol/L=0.084 mmol/LC_L = 0.40 \times 0.21\text{ mmol/L} = 0.084\text{ mmol/L}).
  • Equilibrium Oxygen Concentration (Pure O2\text{O}_2 enriched): C∗≈0.52 mmol/LC^* \approx 0.52\text{ mmol/L}.

# 5.2 Calculating Required Volumetric Mass Transfer (kLareqk_L a_{req})

kLareq=OURmaxC∗−CL=8.96 mmol/L⋅h0.52−0.084 mmol/L=8.960.436=20.55 h−1k_L a_{req} = \frac{\text{OUR}_{max}}{C^* - C_L} = \frac{8.96\text{ mmol/L}\cdot\text{h}}{0.52 - 0.084\text{ mmol/L}} = \frac{8.96}{0.436} = \mathbf{20.55\text{ h}^{-1}}

Adding a 25%25\% control safety margin:

kLadesign≥25.7 h−1k_L a_{design} \ge \mathbf{25.7\text{ h}^{-1}}

# 5.3 Hardware Design for 2,000 L Single-Use Vessel

  • Working Volume (VwV_w): 2,000 L=2.0 m32,000\text{ L} = 2.0\text{ m}^3.
  • Vessel Diameter (TT): 1.30 m1.30\text{ m} (Acol=1.327 m2A_{col} = 1.327\text{ m}^2).
  • Liquid Height (HLH_L): 1.51 m1.51\text{ m} (H/T=1.16H/T = 1.16).
  • Impeller Configuration: Dual 3-blade pitched hydrofoil (Elephant Ear style, down-pumping), diameter D=0.45 mD = 0.45\text{ m} (D/T=0.346D/T = 0.346).
  • Impeller Power Number (NpN_p): 1.451.45.

# Step 1: Agitator Speed Sizing for Constant Power per Volume

Targeting a conservative specific power dissipation P/V=45 W/m3P/V = 45\text{ W/m}^3 (to ensure ηk>22μm\eta_k > 22\mu\text{m}):

P=45 W/m3×2.0 m3=90 WP = 45\text{ W/m}^3 \times 2.0\text{ m}^3 = 90\text{ W}
P=Np⋅ρ⋅N3⋅D5  ⟹  N=(PNp⋅ρ⋅D5)1/3P = N_p \cdot \rho \cdot N^3 \cdot D^5 \implies N = \left( \frac{P}{N_p \cdot \rho \cdot D^5} \right)^{1/3}
N=(901.45×1,020 kg/m3×(0.45 m)5)1/3=(901,479×0.01845)1/3=(9027.29)1/3=1.489 rev/s≈89 RPMN = \left( \frac{90}{1.45 \times 1,020\text{ kg/m}^3 \times (0.45\text{ m})^5} \right)^{1/3} = \left( \frac{90}{1,479 \times 0.01845} \right)^{1/3} = \left( \frac{90}{27.29} \right)^{1/3} = 1.489\text{ rev/s} \approx \mathbf{89\text{ RPM}}

# Step 2: Tip Speed Verification

vtip=π⋅N⋅D=π×1.489 s−1×0.45 m=2.10 m/sv_{tip} = \pi \cdot N \cdot D = \pi \times 1.489\text{ s}^{-1} \times 0.45\text{ m} = \mathbf{2.10\text{ m/s}}
💡 Pro Tip
Hydrodynamic Check: A tip speed of 2.10 m/s2.10\text{ m/s} is well within the acceptable industrial window for mammalian cell culture (1.8–2.5 m/s1.8\text{–}2.5\text{ m/s}), preventing mechanical stress.

# Step 3: Kolmogorov Microscale Calculation

εavg=PρV=90 W2,040 kg=0.0441 W/kg\varepsilon_{avg} = \frac{P}{\rho V} = \frac{90\text{ W}}{2,040\text{ kg}} = 0.0441\text{ W/kg}

Assuming peak local dissipation in the impeller discharge zone is εmax≈12×εavg=0.529 W/kg\varepsilon_{max} \approx 12 \times \varepsilon_{avg} = 0.529\text{ W/kg}:

ηk=((1.0×10−6 m2/s)30.529 W/kg)1/4=(1.89×10−18)1/4=37.1μm\eta_k = \left( \frac{(1.0 \times 10^{-6}\text{ m}^2/\text{s})^3}{0.529\text{ W/kg}} \right)^{1/4} = \left( 1.89 \times 10^{-18} \right)^{1/4} = \mathbf{37.1\mu\text{m}}

Result: Since ηk=37.1μm\eta_k = 37.1\mu\text{m} is significantly larger than the CHO cell diameter (15μm15\mu\text{m}), zero shear-induced cell lysis will occur.

# Step 4: Sparging Strategy (Dual Sparger Architecture)

To decouple oxygen transfer from CO2CO_2 stripping:

  • Microsparger (20–40μm20\text{–}40\mu\text{m} porous frit): Delivers fine oxygen microbubbles dedicated exclusively to meeting kLareqk_L a_{req} at low gas flow rates, minimizing surface bubble burst damage.
  • Drilled-Hole Macrosparger (1.0 mm1.0\text{ mm} orifices): Delivers ballast air (0.05–0.10 vvm=100–200 standard L/min0.05\text{–}0.10\text{ vvm} = 100\text{–}200\text{ standard L/min}) generating larger bubbles that sweep up the liquid column, stripping dissolved CO2CO_2 and maintaining pCO2≤90 mmHgpCO_2 \le 90\text{ mmHg}.

# 6. Bioprocess Scale-Up Checklist

  1. Antioxidant Additive Screening (bDtBPP): Perform gamma-irradiation stability testing on single-use polyethylene contact films. Bis(2,4-di-tert-butylphenyl)phosphate (bDtBPP) leachables inhibit CHO growth at concentrations above 0.1 mg/L0.1\text{ mg/L}.
  2. Kinetics of Base Addition (Plume Mixing): At 2,000 L2,000\text{ L} scale, blend time (τblend\tau_{blend}) stretches to 35–50 seconds35\text{–}50\text{ seconds}. Feed concentrated base (0.5–1.0 M NaOH0.5\text{–}1.0\text{ M NaOH}) directly into the high-velocity discharge stream of the lower impeller to prevent localized alkaline cell killing (pH>8.5\text{pH} > 8.5).
  3. Antifoam Optimization: Excessive silicone emulsion antifoam coats the gas-liquid interface, reducing kLak_L a by up to 50%50\%. Size the bioreactor headspace with a mechanical foam breaker or acoustic resonance defoamer.
Process EngineeringBiopharmaBioreactorsScale-UpmAbsSingle-UseChemical Engineering
Comments (0)

Discussion

Please Log In to participate in the technical discussion.

No comments posted yet. Be the first to share your input!